Story

Ancora Offers to Buy H.B. Fuller's Building Adhesives Unit for $1.2 Billion

ENTHMSVIIDZHZH-TWJAKOHI
Aug 12, 20261 min read
Ancora Offers to Buy H.B. Fuller's Building Adhesives Unit for $1.2 Billion
Text size
Background

Activist investor Ancora Holdings on Wednesday proposed to acquire H.B. Fuller's (NYSE:FUL) Building Adhesive Solutions business for up to $1.2 billion in cash. The offer, detailed in a letter to Fuller's board, represents a significant escalation in Ancora's campaign to reshape the strategy of the specialty chemicals company.

Details of the Offer

Ancora's proposal outlines a cash transaction that the firm argues would be beneficial for H.B. Fuller and its shareholders. In its letter, the investment firm stated it is prepared to sign a confidentiality agreement and commence due diligence immediately.

The activist investor claims it first contacted H.B. Fuller’s CEO and chairman in early July about a potential deal but did not receive a "meaningful response." Ancora accused the company's leadership of prioritizing entrenchment over shareholder interests.

Strategic Rationale

According to Ancora, the divestiture would allow H.B. Fuller to focus its resources on integrating Advanced Medical Solutions, a recent acquisition. Ancora characterized the building adhesives unit as a "low-margin segment" operating in a highly fragmented market.

Sample IUX Markets – In-articleAd

A sale would streamline Fuller's operations and allow management to concentrate on higher-growth areas, the activist firm argued. This move is presented as an alternative strategic path for the company.

Background of Activist Pressure

This offer is the latest development in a contentious relationship between the two firms. In May, Ancora disclosed a stake of more than 2% in H.B. Fuller and publicly criticized the company's agreement to purchase British medical supplier Advanced Medical Solutions Group (LON:AMSU) for approximately £715 million.

At the time, Ancora called the acquisition an "irresponsible pursuit" and urged Fuller to cancel it. The investment firm has a history of activism in the chemicals sector, having also pressured chemical maker Ashland (NYSE:ASH) to pursue a sale.

Read next

More on Stocks
Back to latest news

LATEST